Cargando…
Statins for Renal Patients: A Fiddler on the Roof?
Atherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485511/ https://www.ncbi.nlm.nih.gov/pubmed/23133753 http://dx.doi.org/10.1155/2012/806872 |
_version_ | 1782248309626241024 |
---|---|
author | Guedes, Anabela Malho Neves, Pedro Leão |
author_facet | Guedes, Anabela Malho Neves, Pedro Leão |
author_sort | Guedes, Anabela Malho |
collection | PubMed |
description | Atherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence of chronic kidney disease. Consequently, the use of statins in the general population with dyslipidaemia is not controversial. Nevertheless, the benefits of statins in patients with chronic kidney disease are more elusive. The authors review the possible effects of statins on the progression of renal disease and cardiovascular events in chronic kidney disease patients. |
format | Online Article Text |
id | pubmed-3485511 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-34855112012-11-06 Statins for Renal Patients: A Fiddler on the Roof? Guedes, Anabela Malho Neves, Pedro Leão Int J Nephrol Review Article Atherosclerotic cardiovascular disease is the main cause of morbidity and mortality in chronic kidney disease patients. There is a raft of evidence showing that in the general population dyslipidaemia is associated with an increased risk of cardiovascular events, as well as with a greater prevalence of chronic kidney disease. Consequently, the use of statins in the general population with dyslipidaemia is not controversial. Nevertheless, the benefits of statins in patients with chronic kidney disease are more elusive. The authors review the possible effects of statins on the progression of renal disease and cardiovascular events in chronic kidney disease patients. Hindawi Publishing Corporation 2012-10-22 /pmc/articles/PMC3485511/ /pubmed/23133753 http://dx.doi.org/10.1155/2012/806872 Text en Copyright © 2012 A. M. Guedes and P. L. Neves. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Guedes, Anabela Malho Neves, Pedro Leão Statins for Renal Patients: A Fiddler on the Roof? |
title | Statins for Renal Patients: A Fiddler on the Roof? |
title_full | Statins for Renal Patients: A Fiddler on the Roof? |
title_fullStr | Statins for Renal Patients: A Fiddler on the Roof? |
title_full_unstemmed | Statins for Renal Patients: A Fiddler on the Roof? |
title_short | Statins for Renal Patients: A Fiddler on the Roof? |
title_sort | statins for renal patients: a fiddler on the roof? |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3485511/ https://www.ncbi.nlm.nih.gov/pubmed/23133753 http://dx.doi.org/10.1155/2012/806872 |
work_keys_str_mv | AT guedesanabelamalho statinsforrenalpatientsafiddlerontheroof AT nevespedroleao statinsforrenalpatientsafiddlerontheroof |